{"id":49364,"date":"2022-10-07T14:01:46","date_gmt":"2022-10-07T12:01:46","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/caraway-therapeutics-to-present-at-two-upcoming-investor-conferences\/"},"modified":"2022-10-07T14:01:46","modified_gmt":"2022-10-07T12:01:46","slug":"caraway-therapeutics-to-present-at-two-upcoming-investor-conferences","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/caraway-therapeutics-to-present-at-two-upcoming-investor-conferences\/","title":{"rendered":"Caraway Therapeutics to Present at Two Upcoming Investor Conferences"},"content":{"rendered":"
\n

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Caraway Therapeutics<\/a> today announced that the Company will be participating in two upcoming investor conferences.\n<\/p>\n

<\/a><\/p>\n

\nCaraway\u2019s Chief Executive Officer, Martin D. Williams, will present recent advances in the Company\u2019s TRPML1 program at the Fall Life Sciences Private Company Showcase, co-hosted by BMO Capital Markets, Solebury Strategic Communications and Goodwin in New York, NY on October 13, 2022, from 4:20pm-4:40pm ET.\n<\/p>\n

\nWilliams will also present at the Oppenheimer Private Company Showcase in Palo Alto, CA on October 18, 2022, from 9:25am-9:45am PT.\n<\/p>\n

\n\u201cI look forward to sharing the latest updates on Caraway\u2019s work to develop precision medicines for CNS and rare diseases,\u201d said Williams. \u201cWe continue to progress our TRPML1 program for GBA-Parkinson\u2019s disease and other rare genetic diseases and are looking forward to discussing our progress with investors.”\n<\/p>\n

\nAbout Caraway Therapeutics<\/b>\n<\/p>\n

\nCaraway Therapeutics is a biopharmaceutical company pursuing novel approaches for the treatment of genetically defined neurodegenerative and rare diseases. The company is a leader in the cutting-edge science of activating cellular recycling processes to clear toxic materials and defective cellular components by modulating lysosomal function. Caraway is utilizing its unique product engine to develop proprietary insights into lysosomal function and small molecule ion channel modulation and advance a robust pipeline of precision therapeutic candidates with disease-modifying potential for patients. The company is backed by top-tier investors, including SV Health Investors, AbbVie Ventures, MRLV Fund, Amgen Ventures, Dementia Discovery Fund, Alexandria Venture Investments and Eisai Innovation.\n<\/p>\n

\nCaraway is based in Cambridge, MA. For more information, please visit www.carawaytx.com<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nMedia:<\/b>
MacDougall
\n
Kari Watson or Carolyn Noyes
\n
(781) 235-3060
\n
kwatson@macdougall.bio<\/a> or cnoyes@macdougall.bio<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Caraway Therapeutics today announced that the Company will be participating in two upcoming investor conferences. Caraway\u2019s Chief Executive Officer, Martin D. Williams, will present recent advances in the Company\u2019s TRPML1 program at the Fall Life Sciences Private Company Showcase, co-hosted by BMO Capital Markets, Solebury Strategic Communications and Goodwin in New York, NY … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-49364","6":"format-standard","7":"category-industry"},"yoast_head":"\nCaraway Therapeutics to Present at Two Upcoming Investor Conferences - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/caraway-therapeutics-to-present-at-two-upcoming-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Caraway Therapeutics to Present at Two Upcoming Investor Conferences - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"CAMBRIDGE, Mass.–(BUSINESS WIRE)–Caraway Therapeutics today announced that the Company will be participating in two upcoming investor conferences. Caraway\u2019s Chief Executive Officer, Martin D. Williams, will present recent advances in the Company\u2019s TRPML1 program at the Fall Life Sciences Private Company Showcase, co-hosted by BMO Capital Markets, Solebury Strategic Communications and Goodwin in New York, NY ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/caraway-therapeutics-to-present-at-two-upcoming-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-07T12:01:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221007005053\/en\/837856\/21\/CarawayTx_rgb_large.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/caraway-therapeutics-to-present-at-two-upcoming-investor-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/caraway-therapeutics-to-present-at-two-upcoming-investor-conferences\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Caraway Therapeutics to Present at Two Upcoming Investor Conferences\",\"datePublished\":\"2022-10-07T12:01:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/caraway-therapeutics-to-present-at-two-upcoming-investor-conferences\\\/\"},\"wordCount\":282,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/caraway-therapeutics-to-present-at-two-upcoming-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221007005053\\\/en\\\/837856\\\/21\\\/CarawayTx_rgb_large.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/caraway-therapeutics-to-present-at-two-upcoming-investor-conferences\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/caraway-therapeutics-to-present-at-two-upcoming-investor-conferences\\\/\",\"name\":\"Caraway Therapeutics to Present at Two Upcoming Investor Conferences - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/caraway-therapeutics-to-present-at-two-upcoming-investor-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/caraway-therapeutics-to-present-at-two-upcoming-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221007005053\\\/en\\\/837856\\\/21\\\/CarawayTx_rgb_large.jpg\",\"datePublished\":\"2022-10-07T12:01:46+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/caraway-therapeutics-to-present-at-two-upcoming-investor-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/caraway-therapeutics-to-present-at-two-upcoming-investor-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/caraway-therapeutics-to-present-at-two-upcoming-investor-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221007005053\\\/en\\\/837856\\\/21\\\/CarawayTx_rgb_large.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221007005053\\\/en\\\/837856\\\/21\\\/CarawayTx_rgb_large.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/caraway-therapeutics-to-present-at-two-upcoming-investor-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Caraway Therapeutics to Present at Two Upcoming Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Caraway Therapeutics to Present at Two Upcoming Investor Conferences - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/caraway-therapeutics-to-present-at-two-upcoming-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Caraway Therapeutics to Present at Two Upcoming Investor Conferences - Pharma Trend","og_description":"CAMBRIDGE, Mass.–(BUSINESS WIRE)–Caraway Therapeutics today announced that the Company will be participating in two upcoming investor conferences. Caraway\u2019s Chief Executive Officer, Martin D. Williams, will present recent advances in the Company\u2019s TRPML1 program at the Fall Life Sciences Private Company Showcase, co-hosted by BMO Capital Markets, Solebury Strategic Communications and Goodwin in New York, NY ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/caraway-therapeutics-to-present-at-two-upcoming-investor-conferences\/","og_site_name":"Pharma Trend","article_published_time":"2022-10-07T12:01:46+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221007005053\/en\/837856\/21\/CarawayTx_rgb_large.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/caraway-therapeutics-to-present-at-two-upcoming-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/caraway-therapeutics-to-present-at-two-upcoming-investor-conferences\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Caraway Therapeutics to Present at Two Upcoming Investor Conferences","datePublished":"2022-10-07T12:01:46+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/caraway-therapeutics-to-present-at-two-upcoming-investor-conferences\/"},"wordCount":282,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/caraway-therapeutics-to-present-at-two-upcoming-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221007005053\/en\/837856\/21\/CarawayTx_rgb_large.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/caraway-therapeutics-to-present-at-two-upcoming-investor-conferences\/","url":"https:\/\/pharma-trend.com\/en\/caraway-therapeutics-to-present-at-two-upcoming-investor-conferences\/","name":"Caraway Therapeutics to Present at Two Upcoming Investor Conferences - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/caraway-therapeutics-to-present-at-two-upcoming-investor-conferences\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/caraway-therapeutics-to-present-at-two-upcoming-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221007005053\/en\/837856\/21\/CarawayTx_rgb_large.jpg","datePublished":"2022-10-07T12:01:46+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/caraway-therapeutics-to-present-at-two-upcoming-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/caraway-therapeutics-to-present-at-two-upcoming-investor-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/caraway-therapeutics-to-present-at-two-upcoming-investor-conferences\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221007005053\/en\/837856\/21\/CarawayTx_rgb_large.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221007005053\/en\/837856\/21\/CarawayTx_rgb_large.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/caraway-therapeutics-to-present-at-two-upcoming-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Caraway Therapeutics to Present at Two Upcoming Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49364","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=49364"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49364\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=49364"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=49364"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=49364"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}